Australia markets closed

Anavex Life Sciences Corp. (AVXL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.3700-0.0800 (-1.80%)
As of 10:31AM EDT. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
40,334
43,717
37,916
32,984
25,232
Selling general and administrative
11,331
12,039
13,070
9,018
5,857
Total operating expenses
51,665
55,731
50,986
41,948
30,938
Operating income or loss
-51,665
-55,731
-50,986
-41,948
-30,938
Interest expense
-
964
0
0
-
Total other income/expenses net
2,327
2,678
2,419
4,281
4,501
Income before tax
-43,043
-47,498
-47,620
-37,641
-26,258
Income tax expense
112
7
358
268
22.664
Income from continuing operations
-43,155
-47,505
-47,978
-37,909
-26,280
Net income
-43,155
-47,505
-47,978
-37,909
-26,280
Net income available to common shareholders
-43,155
-47,505
-47,978
-37,909
-26,280
Basic EPS
-0.60
-0.60
-0.62
-0.54
-0.45
Diluted EPS
-0.60
-0.60
-0.62
-0.54
-0.45
Basic average shares
79,788
79,788
76,910
69,803
58,195
Diluted average shares
79,788
79,788
76,910
69,803
58,195